Remove what-we-do study-and-site-materials
article thumbnail

Grand Rounds February 23, 2024: Virtual Vigilance: Monitoring of Decentralized Clinical Trials (Adrian Hernandez, MD; Christopher J. Lindsell, PhD)

Rethinking Clinical Trials

There are 5 guiding principles for defining quality that should inform DCTs: Have we enrolled the right participants according to the protocol with adequate consent? There are 5 guiding principles for defining quality that should inform DCTs: Have we enrolled the right participants according to the protocol with adequate consent?

article thumbnail

Fixing Feasibility: Collaborative Approaches for Redefining and Improving Site Selection

ACRP blog

Aimed at predicting whether a trial at a particular site will succeed, feasibility involves determining whether the site has the necessary patients, staff, technology, and other resources. In turn, site staff must decide whether the site should accept the study based on available resources.{1}

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A 360-degree View on Motivators and Deterrents to Clinical Trial Participation

WCG Clinical

Listen in as we dive into feedback from perspectives across all clinical research stakeholders — sponsors, providers, sites, and patients — for valuable take-aways and insights into the trial experience. Gina, thanks for joining me today and talking about our topic. You might say that I’ve actually grown up with the company.

article thumbnail

How Alexion is Turning Patient Feedback into Actionable Insights in Rare Disease Clinical Trials

XTalks

Patient input is a crucial component of rare disease clinical trials, as it can provide valuable insights into the patient experience and inform decisions about study design and implementation. Could you tell me about your work there and what their mission is? Could you tell me about your work there and what their mission is?

article thumbnail

Clinical Trials Must Evolve to Better Serve LGBTQ+ Community

ACRP blog

Clinical trials are not adequately serving a growing LGBTQ+ population, and the lack of inclusion could put the health of millions at risk, undermine the efficacy of study data, and slow development of critical drugs and treatments, panelists for an ACRP roundtable in honor of Pride Month warned on June 14. “An Langley asked the group.

article thumbnail

Cell & Gene Therapy Product Development: How Can You Build a Successful Partnership with Your CRO’s Project Manager?

XTalks

The selection of a contract research organization (CRO) to support a cell or gene therapy program is crucial during the product’s development, as it can determine the success or failure of a study in meeting timelines and gathering the necessary data for approval.

article thumbnail

New CRISPR-Based Tool Called PASTE Gene Editing Inserts Large DNA Sequences at Desired Sites

XTalks

Developed by MIT researchers Jonathan Gootenberg and Omar Abudayyeh, PASTE (Programmable Addition via Site-specific Targeting Elements) gene editing technology can insert genes as long as 36,000 DNA base pairs to liver cells in mice as well as several types of human cells. Gootenberg and Abudayyeh are the senior authors of the study.